THERAPEUTIC DRUG MONITORING IN THE TREATMENT OF EPILEPSY

Download full text PDF
Issue: 
1
Year: 
2017

Associate Professor D. Dmitrenko (1), MD; Professor N. Shnaider (1), MD; E. Bochanova (1), Candidate of Medical Sciences; Professor I. Artyukhov (1), MD; Professor S. Zyryanov (2), MD; O. Veselova (1), Candidate of Medical Sciences; S. Gusev (1), Candidate of Medical Sciences; T. Potupchik (1), Candidate of Medical Sciences 1-Prof. V.F. Voino-Yasenetsky Krasnoyarsk State Medical University, Krasnoyarsk 2-Peoples’ Friendship University of Russia, Moscow

Introducing the therapeutic drug monitoring of valproic acids can reduce the economic burden of epilepsy; thus this is a clinically justified and pharmacoeconomic aspect of therapeutic management of the above disease.
Keywords: 
epilepsy
management
anti-epileptic drugs
therapeutic drug monitoring
pharmacoeconomics

It appears your Web browser is not configured to display PDF files. Download adobe Acrobat или click here to download the PDF file.

References: 
  1. Hauser W., Annegers J., Kurland L. Incidence of epilepsy and unprovoked seizures in Rochester, Minnesota: 1935–1984 // Epilepsia. – 1993; 34 (3): 453–68.
  2. Kale R. Global campaign against epilepsy: the treatment gap // Epilepsia. – 2002; 43 (6): 31–3.
  3. Jallon P. ILAE workshop report: Epilepsy in developing countries // Epilepsia. – 1997; 38 (10): 1143–51.
  4. McHugh J., Delanty N. Epidemiology and classification of epilepsy: gender comparisons // Int. Rev. Neurobiol. – 2008; 83: 11–26.
  5. Guljaev S.A., Arhipenko I.V., Ovchinnikova A.A. Sovremennye aspekty epidemiologii epilepsii // Rus. zhurn. detskoj nevrol. – 2011; 1: 11–8.
  6. Geht A.B., Mil'chakova L.E., Churilin Ju.Ju. i dr. Epidemiologija epilepsii v Rossii // Zhurn. nevrol. i psihiat. im. S.S. Korsakova. – 2006; 1. (Pril. «Epilepsija»): 3–7.
  7. Shnayder N., Dmitrenko D., Sadykova A. i dr. Epidemiological studies on epilepsy in Siberia // Med. Health Sci. J. – 2011; 6: 35–42.
  8. Sarma A., Khandker N., Kurczewski L. i dr. Medical management of epileptic seizures: challenges and solutions // Neuropsychiatr. Dis. Treat. – 2016; 24 (12): 467–85.
  9. Ekonomicheskoe bremja epilepsii v Rossijskoj Federatsii // URL: http://www.hta-rus.ru/research-2-1/4 (data obraschenija: 11.08.2016).
  10. Vlasov P.N., Orehova N.V., Filatova N.V. i dr. Epilepsija u vzroslyh v kontekste stoimosti zabolevanija // Zhurn. nevrol. i psihiat. im. S.S. Korsakova. – 2010; 110 (3): 44–7.
  11. Shagrova E.V., Orehova N.V., Leonova M.V. i dr. Struktura zatrat na antiepilepticheskuju terapiju po dannym tsentra dlja detej, bol'nyh epilepsiej // Rus. zhurn. detskoj nevrol. – 2012; 7 (3): 17–24.
  12. Jung J., Seo H., Kim Y. et al. The economic burden of epilepsy in Korea, 2010 // J. Prev. Med. Public Health. – 2013; 46 (6): 293–9.
  13. Chang L., Zhu B., Chang J. et al. Economic burden of disease studies in patients with epilepsy // Zhonghua Yu Fang Yi Xue Za Zhi. – 2012; 46 (12): 1084–7.
  14. Belousov Ju.B., Leonova M.V., Shtejnberg L.L. i dr. Primenenie antikonvul'santov s pozitsii monitoringa kontsentratsij: sovremennye dannye // Farmateka. – 2014; 7: 98–103.
  15. Muhin K.Ju., Petruhin A.S., Rykova E.A. Pobochnye effekty antikonvul'santov pri lechenii idiopaticheskoj generalizovannoj epilepsii // Zhurn. nevrol. i psihiat. im. S.S. Korsakova. – 1997; 7: 25–31.
  16. Bochanova E.N., Shnajder N.A., Dmitrienko D.V. i dr. Porjadok oformlenija i registratsii nezhelatel'nyh pobochnyh reaktsij protivoepilepticheskih preparatov. Metod. rekomendatsii / Krasnojarsk: Operativnaja poligrafija, 2016; 82 s.
  17. Vorob'ev P.A., Avksent'eva M.V., Jur'ev A.S. i dr. Kliniko-ekonomicheskij analiz / M.: N'judiamed, 2004; 404 s.
  18. Artjuhov I.P., Sakovich V.A., Valik O.V. i dr. Vnedrenie sovremennyh meditsinskih tehnologij v serdechno-sosudistuju hirurgiju // Sib. med. obozrenie. – 2014; 6: 91–9.